Loading... Please wait... Loading... Please wait...
| Reporting Date | Major Shareholder Name | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| 11/14/2022 | ORBIMED ADVISORS LLC | 8.47 M | $2.31 M | 0.00% | 25.69% |
| 11/14/2022 | VANGUARD GROUP INC | 499,932 | $136,000 | 59.36% | 1.52% |
| 11/14/2022 | RENAISSANCE TECHNOLOGIES LLC | 282,877 | $77,000 | -32.62% | 0.86% |
| 11/14/2022 | BLACKROCK INC. | 170,945 | $47,000 | -2.01% | 0.52% |
| 11/14/2022 | BAKER BROS. ADVISORS LP | 139,105 | $38,000 | -69.19% | 0.42% |
| 11/14/2022 | GEODE CAPITAL MANAGEMENT, LLC | 138,465 | $37,000 | 0.00% | 0.42% |
| 11/14/2022 | CITADEL ADVISORS LLC | 115,925 | $32,000 | 100.00% | 0.35% |
| 11/04/2022 | PRUDENTIAL FINANCIAL INC | 98,600 | $27,000 | 54.06% | 0.30% |
| 11/07/2022 | VIRTU FINANCIAL LLC | 80,774 | $22,000 | 100.00% | 0.25% |
| 11/14/2022 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 53,900 | $15,000 | -22.89% | 0.16% |
| 11/14/2022 | ACADIAN ASSET MANAGEMENT LLC | 50,339 | $13,000 | 0.00% | 0.15% |
| 11/14/2022 | FIDUCIARY TRUST CO | 47,998 | $13,000 | 0.00% | 0.15% |
| 10/06/2022 | INDEPENDENCE BANK OF KENTUCKY | 42,325 | $12,000 | 0.00% | 0.13% |
| 11/15/2022 | STATE STREET CORP | 33,907 | $9,000 | 0.00% | 0.10% |
| 11/14/2022 | NORTHERN TRUST CORP | 29,636 | $8,000 | 0.00% | 0.09% |
| 11/08/2022 | TEXAS YALE CAPITAL CORP. | 20,000 | $5,000 | 0.00% | 0.06% |
| 10/07/2022 | SANDERS MORRIS HARRIS LLC | 15,000 | $4,000 | 0.00% | 0.05% |
| 11/10/2022 | TOWER RESEARCH CAPITAL LLC (TRC) | 11,768 | $3,000 | -46.74% | 0.04% |
| 11/14/2022 | BANK OF NEW YORK MELLON CORP | 10,930 | $3,000 | 0.00% | 0.03% |
| 11/14/2022 | MORGAN STANLEY | 10,725 | $3,000 | -0.01% | 0.03% |
| 11/10/2022 | UBS GROUP AG | 9,848 | $3,000 | -53.71% | 0.03% |
| 11/10/2022 | FMR LLC | 4,000 | $1,000 | -1.23% | 0.01% |
| 11/03/2022 | BARCLAYS PLC | 3,018 | $1,000 | 0.00% | 0.01% |
| 10/27/2022 | US BANCORP \DE\ | 2,000 | $1,000 | 0.00% | 0.01% |
| 10/21/2022 | ENDURANCE WEALTH MANAGEMENT, INC. | 1,500 | $0 | 0.00% | 0.00% |
| 11/14/2022 | WELLS FARGO & COMPANY/MN | 1,231 | $0 | 0.41% | 0.00% |
| 11/09/2022 | GROUP ONE TRADING, L.P. | 1,200 | $0 | 0.00% | 0.00% |
| 11/14/2022 | ADVISOR GROUP HOLDINGS, INC. | 925 | $0 | 0.00% | 0.00% |
| 11/10/2022 | ASPIRE PRIVATE CAPITAL, LLC | 900 | $0 | 0.00% | 0.00% |
| 11/04/2022 | SIMPLEX TRADING, LLC | 640 | $0 | 1,500.00% | 0.00% |
| 11/16/2022 | BNP PARIBAS ARBITRAGE, SNC | 252 | $69 | 0.00% | 0.00% |
| 11/14/2022 | ROYAL BANK OF CANADA | 207 | $0 | 0.00% | 0.00% |
| 11/09/2022 | SALEM INVESTMENT COUNSELORS INC | 175 | $0 | 0.00% | 0.00% |
| 11/02/2022 | BEAIRD HARRIS WEALTH MANAGEMENT, LLC | 114 | $0 | 0.00% | 0.00% |
| 11/10/2022 | INVESTORS RESEARCH CORP | 89 | $0 | 0.00% | 0.00% |
| 10/14/2022 | GRADIENT INVESTMENTS LLC | 65 | $0 | 0.00% | 0.00% |
| 11/14/2022 | JPMORGAN CHASE & CO | 24 | $0 | 100.00% | 0.00% |
| 11/14/2022 | BANK OF AMERICA CORP /DE/ | 1 | $0 | 0.00% | 0.00% |
| 11/14/2022 | FRANKLIN RESOURCES INC | 0 | $0 | -100.00% | 0.00% |
| 11/15/2022 | CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% | 0.00% |
| 11/14/2022 | HOWE & RUSLING INC | 0 | $0 | -100.00% | 0.00% |
| 11/10/2022 | CITIGROUP INC | 0 | $0 | -100.00% | 0.00% |
| 05/14/2024 | GOLDMAN SACHS GROUP INC | 0 | $0 | -100.00% | 0.00% |
| 10/28/2022 | HARBOR CAPITAL ADVISORS, INC. | 0 | $0 | -100.00% | 0.00% |
| 11/14/2022 | CITADEL ADVISORS LLC | 0 | $0 | -100.00% | 0.00% |
| 11/14/2022 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0 | $0 | -100.00% | 0.00% |
| 11/16/2022 | CAPTRUST FINANCIAL ADVISORS | 0 | $0 | -100.00% | 0.00% |
| 11/15/2022 | JANE STREET GROUP, LLC | 0 | $0 | -100.00% | 0.00% |
| 11/15/2022 | LAUREL WEALTH ADVISORS LLC | 0 | $0 | -100.00% | 0.00% |
| 11/07/2022 | STEWARD FINANCIAL GROUP LLC | 0 | $0 | -100.00% | 0.00% |
A. During the previous two years, 3 institutional investors and hedge funds held shares of LogicBio Therapeutics, Inc.. The most heavily invested institutionals were:
Carroll Financial Associates, Inc.: 428
Winslow, Evans & Crocker, Inc.: 176
TEACHERS ADVISORS, LLC: 10,888
A. 31.37% of LogicBio Therapeutics, Inc. stock is owned by institutional investors.
A. Institutional investors have bought a total of 11,492 shares in the last 24 months. This purchase volume represents approximately $66,251 in transactions.
